Vertual's VR system (VERT) is currently used by universities and teaching hospitals across the UK and 30 other countries worldwide for training students and support specialists continue their professional development. VERT allows experimenting with new technologies before implementing them on patients, as well as understanding the implications of instrument variation.
The improved product developed in partnership with NPL will expand the current commercial uses of VERT, with possible applications in the patient-clinician relationship domain. Professionals may use VR to simulate with precision the patient's anatomical structure, which the patient can then visualise before proceeding with treatment. This has the potential to increase patients' confidence and trust in radiation therapy, enable them to understand how treatments will impact their organs and provides greater clarity about radiotherapy procedures.
Vertual Ltd is the leading provider of virtual reality training systems in radiation therapy. Their virtual reality system VERT is used to train radiographers and physicists in universities and teaching hospitals in 32 countries across the world, with new customers choosing to use the VERT training system every year.
The company was formed in 2007 by three founder members as a spin-off company from a joint research project involving the University of Hull and East Yorkshire Hospital Trust. The VERT system was commercialised the following year and research and development on this product, along with new virtual reality training products, continues to be their focus.
Their aim is to create a range of virtual reality training solutions for both the healthcare sector and other sectors that require hands-on technical training in a safe simulated environment.
For more information visit Vertual
Follow Vertual on Twitter
Follow Vertual on YouTube
Follow Vertual on LinkedIn